IMPROVEMENT OF THE REGENERATION OF MYELIN SHEATHS
NT-3 is a useful therapeutic agent for the treatment of demyelination diseases, especially for the treatment of multiple sclerosis. It is administered preferably in doses between 0,01 mu g and 5 mu g/kg body weight in 1 to 10 injections at an interval of 1-21 days. Le NT-3 est un agent thérapeutique...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | BARTKE, ILSE UNGER, JUERGEN |
| description | NT-3 is a useful therapeutic agent for the treatment of demyelination diseases, especially for the treatment of multiple sclerosis. It is administered preferably in doses between 0,01 mu g and 5 mu g/kg body weight in 1 to 10 injections at an interval of 1-21 days.
Le NT-3 est un agent thérapeutique s'utilisant dans le traitement d'affections dues à la démyélinisation, notamment dans le traitement de la sclérose en plaques. Cet agent thérapeutique est administré en doses comprises entre 0,01 et 5 mu g/kg de poids corporel, en 1 à 10 injections, à un intervalle de 1 à 21 jours. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO9856403A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO9856403A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO9856403A13</originalsourceid><addsrcrecordid>eNrjZDD09A0I8g9z9XX1C1Hwd1MI8XBVCHJ1d_VzDXIM8fT3A4n5Rrr6ePopBHu4OoZ4BPMwsKYl5hSn8kJpbgYFN9cQZw_d1IL8-NTigsTk1LzUkvhwf0sLUzMTA2NHQ2MilAAAGFEmag</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>IMPROVEMENT OF THE REGENERATION OF MYELIN SHEATHS</title><source>esp@cenet</source><creator>BARTKE, ILSE ; UNGER, JUERGEN</creator><creatorcontrib>BARTKE, ILSE ; UNGER, JUERGEN</creatorcontrib><description>NT-3 is a useful therapeutic agent for the treatment of demyelination diseases, especially for the treatment of multiple sclerosis. It is administered preferably in doses between 0,01 mu g and 5 mu g/kg body weight in 1 to 10 injections at an interval of 1-21 days.
Le NT-3 est un agent thérapeutique s'utilisant dans le traitement d'affections dues à la démyélinisation, notamment dans le traitement de la sclérose en plaques. Cet agent thérapeutique est administré en doses comprises entre 0,01 et 5 mu g/kg de poids corporel, en 1 à 10 injections, à un intervalle de 1 à 21 jours.</description><edition>6</edition><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>1998</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19981217&DB=EPODOC&CC=WO&NR=9856403A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19981217&DB=EPODOC&CC=WO&NR=9856403A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BARTKE, ILSE</creatorcontrib><creatorcontrib>UNGER, JUERGEN</creatorcontrib><title>IMPROVEMENT OF THE REGENERATION OF MYELIN SHEATHS</title><description>NT-3 is a useful therapeutic agent for the treatment of demyelination diseases, especially for the treatment of multiple sclerosis. It is administered preferably in doses between 0,01 mu g and 5 mu g/kg body weight in 1 to 10 injections at an interval of 1-21 days.
Le NT-3 est un agent thérapeutique s'utilisant dans le traitement d'affections dues à la démyélinisation, notamment dans le traitement de la sclérose en plaques. Cet agent thérapeutique est administré en doses comprises entre 0,01 et 5 mu g/kg de poids corporel, en 1 à 10 injections, à un intervalle de 1 à 21 jours.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1998</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDD09A0I8g9z9XX1C1Hwd1MI8XBVCHJ1d_VzDXIM8fT3A4n5Rrr6ePopBHu4OoZ4BPMwsKYl5hSn8kJpbgYFN9cQZw_d1IL8-NTigsTk1LzUkvhwf0sLUzMTA2NHQ2MilAAAGFEmag</recordid><startdate>19981217</startdate><enddate>19981217</enddate><creator>BARTKE, ILSE</creator><creator>UNGER, JUERGEN</creator><scope>EVB</scope></search><sort><creationdate>19981217</creationdate><title>IMPROVEMENT OF THE REGENERATION OF MYELIN SHEATHS</title><author>BARTKE, ILSE ; UNGER, JUERGEN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO9856403A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>1998</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>BARTKE, ILSE</creatorcontrib><creatorcontrib>UNGER, JUERGEN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BARTKE, ILSE</au><au>UNGER, JUERGEN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>IMPROVEMENT OF THE REGENERATION OF MYELIN SHEATHS</title><date>1998-12-17</date><risdate>1998</risdate><abstract>NT-3 is a useful therapeutic agent for the treatment of demyelination diseases, especially for the treatment of multiple sclerosis. It is administered preferably in doses between 0,01 mu g and 5 mu g/kg body weight in 1 to 10 injections at an interval of 1-21 days.
Le NT-3 est un agent thérapeutique s'utilisant dans le traitement d'affections dues à la démyélinisation, notamment dans le traitement de la sclérose en plaques. Cet agent thérapeutique est administré en doses comprises entre 0,01 et 5 mu g/kg de poids corporel, en 1 à 10 injections, à un intervalle de 1 à 21 jours.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO9856403A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | IMPROVEMENT OF THE REGENERATION OF MYELIN SHEATHS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T11%3A29%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BARTKE,%20ILSE&rft.date=1998-12-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO9856403A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |